Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
AssigneeWarner-Lambert Company
InventorsClifton J. Blankley, John C. Hodges, Sylvester Klutchko
Life of this patent
Estimating the term…
Abstract
This invention relates to novel substituted 1,2,3,4-tetrahydroisoquinolines which are useful in the treatment of vascular restenosis, various disorders of the central nervous system, in the regulation of female reproductive functions, in cognitive enhancement, in atherosclerosis and in treating excessive AVP secretory disorders. Novel intermediates useful in the preparation of the compounds are also disclosed. Methods of using the compounds and pharmaceutical compositions containing them are disclosed.
Claims7
A compound of Formula I ##STR58## or a pharmaceutically acceptable salt thereof wherein:
- R.sub.1 and R.sub.2 are each independently hydrogen, lower alkyl, halogen, hydroxy, alkoxy, amino, alkylamino, dialkylamino, acylamino, CF.sub.3, carboxy, carboalkoxy, hydroxyalkyl, aminoalkyl, and nitro;
- n is an integer from zero to 4;
- X is absent, O, S, NH, N-alkyl, and is attached to the tetrahydroisoquinoline at the 5 or 6 position;
- R.sub.3 is hydrogen, alkoxy, aralkoxy, alkylthio, or halogen;
- R.sub.4 is hydrogen, alkyl, hydroxyalkyl, CO.sub.2 R.sub.6, CON(R.sub.6).sub.2 wherein R.sub.6 is hydrogen or lower alkyl;
- and
- R.sub.5 is alkyl, aryl, aralkyl which can be unsubstituted or substituted on the alkyl and/or on the aryl portion, diaralkyl, the aryl portion can be unsubstituted or substituted, COR.sub.7, SO.sub.2 R.sub.7 wherein R.sub.7 is aralkyl, alkyl, diaralkyl, OR.sub.8, NR.sub.8 R.sub.9 wherein R.sub.8 and R.sub.9 are each independently hydrogen, alkyl, cycloalkyl, aryl, or aralkyl Wherein aryl is phenyl or naphthyl and the substituents are one or more selected from:
- alkyl, alkoxy, hydroxy, halogen, NO.sub.2, NH.sub.2, NHalkyl, N(alkyl).sub.2, SCH, and SH.
A compound of formula ##STR59## or a pharmaceutically acceptable salt thereof wherein R.sub.1 and R.sub.2 are each independently hydrogen, methoxy, carboxy, methyl, nitro, or amino;
- n is 0, 1, or 2;
- X is O, NH, or NCH.sub.3 ;
- R.sub.3 is H, --SCH.sub.3, or --OCH.sub.3 ;
- R.sub.4 is --COOH, COOCH.sub.3, COOC.sub.2 H.sub.5, --CONH.sub.2, and ##STR60## R.sub.5 is hydrogen, ##STR61##
A compound selected from:
- 2-(Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquin olinecarboxylic acid,
- 2-(Diphenylacetyl)-1,2,3,4-tetrahydro-7-methoxy-6-(phenylmethoxy)-3-isoquin olinecarboxylic acid,
- 2-(Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(2-phenylethoxy)-3-isoqui nolinecarboxylic acid,
- 2-[Bis(4-chlorophenyl)acetyl]-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy )-3-isoquinolinecarboxylic acid,
- 2-(Cyclopentylphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)- 3-isoquinolinecarboxylic acid,
- 2-[(2,6-Dichlorophenyl)acetyl]-1,2,3,4-tetrahydro 6-methoxy-5-(phenylmethoxy) 3-isoquinolinecarboxylic acid,
- 1,2,3,4-Tetrahydro 6-methoxy 2-(methylphenylamino)carbonyl]-5-(phenylmethoxy) -3-isoquinolinecarboxylic acid,
- 1,2,3,4-Tetrahydro-6-methoxy-2-[[(4-methoxyphenyl)amino]carbonyl]-5-(phenyl methoxy) 3-isoquinolinecarboxylic acid,
- 2-[[(4-Fluorophenyl)amino]carbonyl]-1,2,3,4-tetrahydro-6-methoxy-5-(phenylm ethoxy) 3-isoquinolinecarboxylic acid,
- 2-(Di(phenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-phenylmethoxy-3-isoquino linecarboxylic acid, ethyl ester,
- 5-[(4-Carbomethoxyphenyl)methoxy]-2-(diphenylacetyl)-1,2,3,4 tetrahydro-6-methoxy-3-isoquinolinecarboxylic acid, ethyl ester,
- 5-(4-Carboxyphenylmethoxy)-2-(diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy- 3-isoquinolinecarboxylic acid,
- 2-(Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5 [(4-methoxy-3-methylphenyl)methoxy]-3-isoquinolinecarboxylic acid, ethyl ester,
- 2-(Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-[(4-methoxy-3-methylpheny l)methoxy]-3-isoquinolinecarboxylic acid,
- 2-(Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(4-nitrophenoxy)-3-isoqui nolinecarboxylic acid, methyl ester,
- 5-(4-Aminophenoxy)-2-(diphenylacetyl) -1,2,3,4-tetrahydro-6 methoxy-3-isoquinolinecarboxylic acid, methyl ester,
- 5-(4-Aminophenoxy)-2-(diphenylacetyl) -1,2,3,4-tetrahydro-6-methoxy-3-isoquinolinecarboxylic acid, and
- (+)-2-(Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-iso quinolinecarboxylic acid.
Dependencies are inferred from the claim text.